🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Happy to share our clinical study on Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation medrxiv.org/content/10.110… Thanks to all my colleagues, staff and students for your great work.

Prepare the pentobarbital.

The largest genome-wide association study for type 2 diabetes so far, which included several ancestry groups, led to the identification of eight clusters of genetic risk variants go.nature.com/3xzZ27i

Australia's Great Barrier Reef is currently experiencing its worst mass bleaching event on record — warming waters brought on by climate change are to blame go.nature.com/3xPPmW4

We’ve known about tolerant CD8+ T cells for >25 yrs – but what are these cells?! Prematurely exhausted, stalled effectors, or something else? Our latest Immunity paper takes a deep dive into this question with some unexpected results, including a link to cancer… (1/)

🎉 We just hit 100 followers! 🎉 Thank you for your support in advancing the field of #T1D. Let's keep growing our network! 🌟 Share, retweet, and invite others to join the #IDS community. Together, we can make a difference! 💪#GrowWithUs

Another reason to keep your fibre intake up! 🍎 Our new study in Nature Microbiology shows that fibre regulates gut microbial #metabolism of tryptophan directing it from producing detrimental indole (and indoxyl-sulfate) to beneficial indolepropionic acid 🤩 nature.com/articles/s4156…

👋 Meet the Organizing Committee! @professorcm is hosting the upcoming #IDS2024👀See you in Bruges? 📅 Don’t miss the registration & abstract deadline: 31 July!

All these Americans saying it’s simply not possible to replace a leader with only 6 weeks’ notice would lose their minds if they knew how Australian politics works. 24 hours on the phones, 10-minute vote. Job done

Ph.D. viva possible questions

We're thrilled to share the new paper on a Multi-omics analysis, output of the recently terminated EU-funded INNODIA Projects. This study analyzed 100 T1D samples from the INNODIA Natural History Study. Proud of this success! #T1D #INNODIA doi.org/10.1002/dmrr.3…

Thanks Cell Host & Microbe Jacobs Lab highlight our MOMmy cohort Gestational diabetes mellitus-Gut microbiome paper with a strong translational relevance published in the same issue of Cell Host & Microbe. Lin ZHANG Siew Ng Francis Chan MD Microbiota I-Center CUHK Medicine

Beyond short-chain fatty acids: Non-SCFA microbial metabolites associated with fiber fermentation and host health Check out our new review cell.com/trends/endocri… in Trends in Endocrinology & Metabolism

Congratulations to Dr Jeniffer Loaiza Naranjo, graduating from the Hamilton-Williams lab with her PhD developing antigen-specific immunotherapy for type 1 diabetes @jennylofer00 #UQFrazerInstitute UQ Medicine #Type1Diabetes

ENDIA is an ongoing Australian cohort study investigating prenatal & early-life exposures driving the development of #isletautoimmunity & #type1diabetes. This paper describes the cohort’s parental demographics, maternal & neonatal outcomes genotypes. drc.bmj.com/panels_ajax_ta…

NHMRC-funded researcher A/Professor Emma Hamilton-Williams from UQ News is using her 2023 Ideas Grant to research how gut microbial metabolites can potentially prevent type 1 diabetes and reduce the burden of this chronic condition #NationalDiabetesWeek2024

Are you attending #IDSBruges2024? Sign up for our Women Inspiring & Elevating Leadership in Diabetes networking session. #networking #WomenInScience

🧪 What I wish I'd known about lab notebooks in year 1: A thread about what has actually worked for me (learned the hard way...) 🧵

Today I celebrated with my team my recent promotion to Professor at The University of Queensland. Thank you so much to all those that supported me on this journey.

Mouse and human data suggests that a potent SCFA immunomodulator promotes multiple beneficial pathways and supports targeting the microbiota as an approach against #T1D nature.com/articles/s4146… Nature Communications